|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q57160113
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241120235942.0 |
|
008
|
|
|
241120nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q57160113
|
|
024
|
|
|
‡a
0000-0002-0473-1447
‡2
orcid
|
|
035
|
|
|
‡a
(OCoLC)Q57160113
|
|
100
|
0 |
|
‡a
Diana Gutiérrez
‡c
researcher
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Diana Gutiérrez
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Advanced engineering of third-generation lysins and formulation strategies for clinical applications
|
|
670
|
|
|
‡a
Author's Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus?
|
|
670
|
|
|
‡a
Author's 'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.
|
|
670
|
|
|
‡a
Author's Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry
|
|
670
|
|
|
‡a
Author's Effective removal of staphylococcal biofilms by the endolysin LysH5.
|
|
670
|
|
|
‡a
Author's Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential
|
|
670
|
|
|
‡a
Author's Isolation and Characterization of Bacteriophages Infecting Staphylococcus epidermidis
|
|
670
|
|
|
‡a
Author's Molecular characterization and antimicrobial susceptibility of Staphylococcus aureus from small-scale dairy systems in the highlands of Central México
|
|
670
|
|
|
‡a
Author's Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology
|
|
670
|
|
|
‡a
Author's Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.
|
|
670
|
|
|
‡a
Author's Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand.
|
|
670
|
|
|
‡a
Author's Role of the Pre-neck Appendage Protein (Dpo7) from Phage vB_SepiS-phiIPLA7 as an Anti-biofilm Agent in Staphylococcal Species
|
|
670
|
|
|
‡a
Author's The Behavior of Staphylococcus aureus Dual-Species Biofilms Treated with Bacteriophage phiIPLA-RODI Depends on the Accompanying Microorganism
|
|
670
|
|
|
‡a
Author's Three proposed new bacteriophage genera of staphylococcal phages: "3alikevirus", "77likevirus" and "Phietalikevirus".
|
|
670
|
|
|
‡a
Author's Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.
|
|
670
|
|
|
‡a
Author's Typing of bacteriophages by randomly amplified polymorphic DNA
|
|
670
|
|
|
‡a
Author's Typing of bacteriophages by randomly amplified polymorphic DNA (RAPD)-PCR to assess genetic diversity.
|
|
909
|
|
|
‡a
(orcid) 0000000204731447
‡9
1
|
|
919
|
|
|
‡a
artilysationofendolysinλsa2lysstronglyimprovesitsenzymaticandantibacterialactivityagainststreptococci
‡A
'Artilysation' of endolysin λSa2lys strongly improves its enzymatic and antibacterial activity against streptococci.
‡9
1
|
|
919
|
|
|
‡a
advancedengineeringof3generationlysinsandformulationstrategiesforclinicalapplications
‡A
Advanced engineering of third-generation lysins and formulation strategies for clinical applications
‡9
1
|
|
919
|
|
|
‡a
arephagelyticproteinsthesecretweapontokillstaphylococcusaureus
‡A
Are Phage Lytic Proteins the Secret Weapon To Kill Staphylococcus aureus?
‡9
1
|
|
919
|
|
|
‡a
typingofbacteriophagesbyrandomlyamplifiedpolymorphicdnarapdpcrtoassessgeneticdiversity
‡A
Typing of bacteriophages by randomly amplified polymorphic DNA (RAPD)-PCR to assess genetic diversity.
‡9
1
|
|
919
|
|
|
‡a
typingofbacteriophagesbyrandomlyamplifiedpolymorphicdna
‡A
Typing of bacteriophages by randomly amplified polymorphic DNA
‡9
1
|
|
919
|
|
|
‡a
2phagesphiiplarodiandphiiplac1clysemonoanddualspeciesstaphylococcalbiofilms
‡A
Two Phages, phiIPLA-RODI and phiIPLA-C1C, Lyse Mono- and Dual-Species Staphylococcal Biofilms.
‡9
1
|
|
919
|
|
|
‡a
3proposednewbacteriophagegeneraofstaphylococcalphages3alikevirus77likevirusandphietalikevirus
‡A
Three proposed new bacteriophage genera of staphylococcal phages: "3alikevirus", "77likevirus" and "Phietalikevirus".
‡9
1
|
|
919
|
|
|
‡a
behaviorofstaphylococcusaureusdualspeciesbiofilmstreatedwithbacteriophagephiiplarodidependsontheaccompanyingmicroorganism
‡A
The Behavior of Staphylococcus aureus Dual-Species Biofilms Treated with Bacteriophage phiIPLA-RODI Depends on the Accompanying Microorganism
‡9
1
|
|
919
|
|
|
‡a
roleofthepreneckappendageproteindpo7fromphagevbsepisphiipla7asanantibiofilmagentinstaphylococcalspecies
‡A
Role of the Pre-neck Appendage Protein (Dpo7) from Phage vB_SepiS-phiIPLA7 as an Anti-biofilm Agent in Staphylococcal Species
‡9
1
|
|
919
|
|
|
‡a
phagesensitivityandprophagecarriageinstaphylococcusaureusisolatedfromfoodsinspainandnewzealand
‡A
Phage sensitivity and prophage carriage in Staphylococcus aureus isolated from foods in Spain and New Zealand.
‡9
1
|
|
919
|
|
|
‡a
phagelyticproteinsbiotechnologicalapplicationsbeyondclinicalantimicrobials
‡A
Phage lytic proteins: biotechnological applications beyond clinical antimicrobials.
‡9
1
|
|
919
|
|
|
‡a
monitoringinrealtimetheformationandremovalofbiofilmsfromclinicalrelatedpathogensusinganimpedancebasedtechnology
‡A
Monitoring in Real Time the Formation and Removal of Biofilms from Clinical Related Pathogens Using an Impedance-Based Technology
‡9
1
|
|
919
|
|
|
‡a
molecularcharacterizationandantimicrobialsusceptibilityofstaphylococcusaureusfromsmallscaledairysystemsinthehighlandsofcentralmexico
‡A
Molecular characterization and antimicrobial susceptibility of Staphylococcus aureus from small-scale dairy systems in the highlands of Central México
‡9
1
|
|
919
|
|
|
‡a
isolationandcharacterizationofbacteriophagesinfectingstaphylococcusepidermidis
‡A
Isolation and Characterization of Bacteriophages Infecting Staphylococcus epidermidis
‡9
1
|
|
919
|
|
|
‡a
genomiccharacterizationof2staphylococcusepidermidisbacteriophageswithantibiofilmpotential
‡A
Genomic characterization of two Staphylococcus epidermidis bacteriophages with anti-biofilm potential
‡9
1
|
|
919
|
|
|
‡a
effectiveremovalofstaphylococcalbiofilmsbytheendolysinlysh5
‡A
Effective removal of staphylococcal biofilms by the endolysin LysH5.
‡9
1
|
|
919
|
|
|
‡a
bacteriophagesasweaponsagainstbacterialbiofilmsinthefoodindustry
‡A
Bacteriophages as Weapons Against Bacterial Biofilms in the Food Industry
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
LC|ns2022001212
|
|
996
|
|
|
‡2
LC|no2011192813
|
|
996
|
|
|
‡2
RERO|A026089228
|
|
996
|
|
|
‡2
LC|ns2013001809
|
|
996
|
|
|
‡2
LC|n 83170738
|
|
996
|
|
|
‡2
LC|n 2018043834
|
|
996
|
|
|
‡2
ISNI|0000000026255918
|
|
996
|
|
|
‡2
LC|no2022043811
|
|
996
|
|
|
‡2
ISNI|0000000423454523
|
|
996
|
|
|
‡2
LC|no2023130862
|
|
996
|
|
|
‡2
BNE|XX1628079
|
|
996
|
|
|
‡2
DNB|121969682X
|
|
996
|
|
|
‡2
BNC|981058581342606706
|
|
996
|
|
|
‡2
LC|ns2013004058
|
|
996
|
|
|
‡2
BNCHL|10000000000000000865391
|
|
996
|
|
|
‡2
LC|no2009138428
|
|
996
|
|
|
‡2
DNB|1016184107
|
|
996
|
|
|
‡2
BNE|XX5611124
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
